Summary: There is no universal medical requirement to gradually wean off GLP-1 receptor agonists, as they do not typically cause physical dependence or withdrawal symptoms requiring dose tapering
Philos Trans R Soc Lond B Biol Sci (2013) 368(1615):20110375.10.1098/rstb.2011.0375 203 MosienkoVBertBBeisDMatthesSFinkHBaderMet alExaggerated aggression and decreased anxiety in mice deficient in brain serotonin
You should look for a board-certified dermatologist, plastic surgeon, or a highly-trained registered nurse or physician assistant working under direct medical supervision
Acknowledgements This work was supported by grants from the National Research Foundation of Korea (NRF-2015M3A9E6028674, NRF-2016R1A5A1010764, and NRF-2017M3A9D8064193), the Institute for Basic Science from the Ministry of Science, ICT, and Future Planning of Korea (IBS-R008-D1), and Suh Kyungbae Foundation
It outperformed semaglutide head-to-head in the SURPASS-2 trial for both glycaemic control and weight loss
In this narrative review, we comprehensively summarized the extracts of various plant species and purified phytochemicals isolated from plants, their targets and mechanism of action, and dosage used in various animal models against epilepsy
